Inflammatix

Interpreting the immune response to better diagnose disease

San Francisco Bay Area, United States · Founded 2016

Employees
51–200
Founded
2016
Business Model
B2B
Last Round
Series ESep 2024
Rounds
5

About

Inflammatix is a molecular diagnostics company developing rapid tests that read the immune system to resolve major clinical and public health challenges. Its TriVerity test provides three actionable scores — bacterial infection likelihood, viral infection likelihood, and illness severity — empowering emergency clinicians to make faster, more confident decisions.

Summary

Inflammatix is a Healthcare company based in San Francisco Bay Area, United States, founded in 2016. Its most recent funding was a Series E round in Sep 2024. Investors include Northpond Ventures, D1 Capital Partners and Khosla Ventures.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ESeries ESep 2024

Sign up to see all 5 rounds

Series A through Series E — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Inflammatix on Indexed.vc
<a href="https://indexed.vc/companies/inflammatix"><img src="https://indexed.vc/api/badge/company/inflammatix" alt="Inflammatix on Indexed.vc" width="260" height="76" /></a>